Brief: Biosynex: COVID-19 IgG/IgM Test Authorised By Ministry Of Health
May 25 (Reuters) - BIOSYNEX SA ALBIO.PA :
* ANNOUNCES INCLUSION OF ITS RAPID SEROLOGICAL TEST COVID-19
IGG/IGM ON THE LIST OF PRODUCTS AUTHORIZED BY THE MINISTRY OF
HEALTH
Source text for Eikon: ID:nBw6QX52ma
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals